Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
02157 LEPU BIO-B
6.980+0.120+1.75%
Closed
02/01 16:08 CCT
High
7.070
Open
6.860
Turnover
7.01M
Low
6.800
Pre Close
6.860
Volume
1.01M
Price Forecast
News
Comment
Lepu Biopharma H1 Loss Goes Down
08:54 AM EDT, 09/27/2022 (MT Newswires) -- Lepu Biopharma's (HKG:2157) first-half attributable loss witnessed a decrease in 2022, as compared to the same period last year. The company's loss stood at
Interim report of Lepu Biology-BRV 2022
Biden Signs Order to Curb China in Biotechnology Following Chip Bill
The US government is reported to introduce new regulations next month to prohibit American companies from exporting chipmaking equipment to Chinese factories that produce advanced semiconductors with sub-14 nanometer processes.
Lepu Bio, Prudential Added to Shenzhen-Hong Kong Stock Connect Trading Link
08:33 AM EDT, 09/05/2022 (MT Newswires) -- Lepu Biopharma (HKG:2157), Prudential (HKG:2378) and Productive Technologies (HKG:0650) were added as constituents to the Shenzhen-Hong Kong Stock Connect to
Lepu Biopharma to Vote Sept. 16 on Shanghai IPO Proposal
09:15 AM EDT, 09/01/2022 (MT Newswires) -- Lepu Biopharma (HKG:2157) will hold a shareholder meeting on Sept. 16 to vote on the company's proposed secondary listing, according to a Thursday disclosure
Lepu Biology-B: interim results announcement for the six months ended June 30, 2022
China Clears Market Launch of Lepu Biopharma's Cancer Drug
06:46 AM EDT, 07/22/2022 (MT Newswires) -- Lepu Biopharma's (HKG:2157) Puyuoheng was granted conditional marketing approval in mainland China, allowing the biotech firm to launch and commercialize the
Shandong Boan Biotechnology Files for Hong Kong IPO
04:21 AM EDT, 05/16/2022 (MT Newswires) -- Shandong Boan Biotechnology filed its initial public offering application in Hong Kong and hired UBS Securities and Essence Corporate Finance as joint sponso
Lepu Biology-BRV 2021 Annual report
Lepu Biology-B: annual results announcement for the year ended December 31, 2021
Company Overview
More
Lepu Biotechnology Co., Ltd. is an innovative biopharmaceutical company based in China and focusing on the field of cancer treatment for the world. We have developed a strong product pipeline focusing on oncolog-focused drug candidates, including clinical and preclinical ADCs, oncolytic virus drugs, and immunotherapy. We plan to commercialize the product pipeline domestically by building a professional sales and marketing team, and promote the product pipeline to overseas markets such as the US and Europe through cooperation with overseas companies.
CEO： Zhongjie Pu
Market： Hong Kong motherboard
Listing Date： 02/23/2022
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet